The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Summary: Background: Vitiligo is a chronic disorder causing skin depigmentation with global prevalence varying from 0·2% to 1·8%. U.K. guidelines recommend assessment of psychological state during clinical evaluation of vitiligo. However, the prevalence of psychological comorbidity in people with vitiligo has not been described. Objectives: To establish the prevalence of psychological symptoms or disorders in people with vitiligo and describe the outcome measures used. Methods: We performed a comprehensive search of MEDLINE, Embase, CINAHL and PsycINFO to identify observational studies assessing the prevalence of psychological symptoms or disorders (December 2016). DerSimonian and Lard random-effects models were used to estimate the overall pooled prevalence. Results: We identified 29 studies with 2530 people with vitiligo. Most studies included a measure of either depression (n =25) or anxiety (n =13). The commonest tools were the Hospital Anxiety and Depression Scale and the Centre for Epidemiology Studies Depression Scale. Ten studies provided information on 13 other psychological outcomes. Pooled prevalence using depression-specific and anxiety-specific questionnaires was 0·29 [95% confidence interval (CI) 0·21–0·38] and 0·33 (95% CI 0·18–0·49), respectively. Prevalence was lower for clinically diagnosed depression (0·21, 95% CI 0·15–0·28) and anxiety (0·15, 95% CI 0·06–0·24). When nonspecific tools were used the prevalence remained similar for depression (0·27, 95% CI 0·08–0·46) but increased for anxiety (0·46, 95% CI 0·39–0·52). High heterogeneity was observed. Conclusions: A range of psychological outcomes are common in people with vitiligo. The prevalence of anxiety was influenced by type of screening tool, suggesting the need for validation of psychological outcome screening tools in the field of dermatology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kennedy-Martin, T., Curtis, S., Faries, D., Robinson, S., & Johnston, J. (2015) · Trials · doi:10.1186/s13063-015-1023-4 · Cited by 878
Psychiatric morbidity in dermatological outpatients: an issue to be recognized
Picardi, A., Abeni, D., Melchi, C. F., Puddu, P., & Pasquini, P. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03831.x · Cited by 413
Living with vitiligo: Dealing with difference
Thompson, A. R., Kent, G., & Smith, J. A. (2002) · British Journal of Health Psychology · doi:10.1348/135910702169457 · Cited by 141
Thompson, A. R., Clarke, S. A., Newell, R. J., Gawkrodger, D. J., & The Appearance Research Collaboration (ARC) (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09828.x · Cited by 121
Self-citationPsychiatric Morbidity in Vitiligo and Psoriasis: A Comparative Study from India
Mattoo, S. K., Handa, S., Kaur, I., Gupta, N., & Malhotra, R. (2001) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2001.tb00004.x · Cited by 108 · cited 8×
“(2015)(51) India 50 10 Healthy comparators 50 0 DSM – IV criteria Suicidal attempts Sharma et al. (2001)(29) India 30 3 3 Psoriasis 30 3 3 DSM – IV Saleh et al. (2008)(35) Egypt 50 2 Psoriasis 50 4 DSM – IV Alopecia areata 50 2 Panic disorder Karelson et al. (2012)(45) Estonia 54 2 Psoriasis 57 Not stated ES-Q Healthy…”
BackgroundInfluential
Research works printed but not linked: 50
- Ezzedine, 2015, Vitiligo, Lancet, 386, 74, 10.1016/S0140-6736(14)60763-7 · DOI · Paper page
- Gawkrodger, 2008, Guidelines for the diagnosis and management of vitiligo, Br J Dermatol, 159, 1051, 10.1111/j.1365-2133.2008.08881.x · DOI · Paper page
- Zhang, 2016, The prevalence of vitiligo: a meta-analysis, PLOS ONE, 11, e163806
- Sandoval-Cruz, 2011, Immunopathogenesis of vitiligo, Autoimmun Rev, 10, 762, 10.1016/j.autrev.2011.02.004 · DOI · Paper page
- Richmond, 2013, Innate immune mechanisms in vitiligo: danger from within, Curr Opin Immunol, 25, 676, 10.1016/j.coi.2013.10.010 · DOI · Paper page
- Gey, 2013, Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms, Br J Dermatol, 168, 756, 10.1111/bjd.12166 · DOI
- Whitton, 2015, Interventions for vitiligo, Cochrane Database Syst Rev, 2, CD003263
- Lilly, 2013, Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL), J Am Acad Dermatol, 69, e11, 10.1016/j.jaad.2012.01.038 · DOI · Paper page
- Jayaprakasam, 2002, Comparison of assessments of severity and quality of life in cutaneous disease, Clin Exp Dermatol, 27, 306, 10.1046/j.1365-2230.2002.01025.x · doi:10.1046/j.1365-2230.2002.01025.x
- Harlow, 2000, Impaired quality of life of adults with skin disease in primary care, Br J Dermatol, 143, 979, 10.1046/j.1365-2133.2000.03830.x · DOI
- Halioua, 2000, Quality of life in dermatology, Int J Dermatol, 39, 801, 10.1046/j.1365-4362.2000.00793.x · DOI
- Kent, 1996, Psychologic effects of vitiligo: a critical incident analysis, J Am Acad Dermatol, 35, 895, 10.1016/S0190-9622(96)90112-7 · DOI · Paper page
- Hann, 2000, Vitiligo, 10.1002/9780470760116 · DOI
- Lai, 2017, Vitiligo and depression: a systematic review and meta-analysis of observational studies, Br J Dermatol, 177, 708, 10.1111/bjd.15199 · DOI · Paper page
- Eleftheriadou, 2011, Future research into the treatment of vitiligo: where should our priorities lie? Results of the vitiligo priority setting partnership, Br J Dermatol, 164, 530
- Morrison, 2017, Quality of life in people with vitiligo: a systematic review and meta-analysis, Br J Dermatol, 177, e338, 10.1111/bjd.15933 · DOI · Paper page
- Moher, 2009, Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement, PLOS Med, 6, e1000097, 10.1371/journal.pmed.1000097 · DOI · Paper page
- Ottawa Hospital Research Institute, The Newcastle Ottawa Scale for assessing quality of nonrandomised studies in meta-analysis
- National Heart, Lung and Blood Institute, Quality assessment of case-control studies
- National Heart, Lung and Blood Institute, Quality assessment tool for observational cohort and cross-sectional studies
- DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 · DOI · Paper page
- Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
- Porter, 1987, Response to cosmetic disfigurement: patients with vitiligo, Cutis, 39, 493
- Delfino, 1988, Personality profiles in patients with alopecia areata, Annal Ital Dermatol, 42, 271
- Vilella, 1998, Vitiligo: psychological aspects, Rev Hosp Psiquiatr La Habana, 29, 463
- Sharma, 2001, Psychiatric morbidity in psoriasis and vitiligo: a comparative study, J Dermatol, 28, 419, 10.1111/j.1346-8138.2001.tb00003.x · DOI · Paper page
- Mattoo, 2002, Psychiatric morbidity in vitiligo: prevalence and correlates in India, J Eur Acad Dermatol Venereol, 16, 573, 10.1046/j.1468-3083.2002.00590.x · DOI · Paper page
- Sampogna, 2004, Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions, Psychosom Med, 66, 620, 10.1097/01.psy.0000132869.96872.b2 · DOI
- Mechri, 2006, Psychiatric morbidity and quality of life in vitiligo: a case controlled study, Tunis Med, 84, 632
- Ahmed, 2007, Frequency and pattern of psychiatric disorders in patients with vitiligo, J Ayub Med Coll Abbottabad, 19, 19
- Arýcan, 2008, Clinical characteristics in 113 Turkish vitiligo patients, Acta Dermatoven Alp Pannonica Adrita, 17, 129
- Saleh, 2008, Comparative study of psychiatric morbidity and QoL in psoriasis, vitiligo and alopecia, Egypt Dermatol Online J, 4, 1
- Sampogna, 2008, Identification of categories at risk for high quality of life impairment in patients with vitiligo, Br J Dermatol, 159, 351, 10.1111/j.1365-2133.2008.08678.x · DOI
- Nogueira, 2009, [Vitiligo and Emotions], An Bras Dermatol, 84, 41, 10.1590/S0365-05962009000100006 · DOI
- Osman, 2009, The psychological impact of vitiligo in adult Sudanese patients, Afr J Psych, 12, 284, 10.4314/ajpsy.v12i4.49045 · DOI
- AlGhamdi, 2010, Beliefs and perceptions of Arab vitiligo patients regarding their condition, Int J Dermatol, 49, 1141, 10.1111/j.1365-4632.2010.04514.x · DOI
- Bashir, 2010, Depression in adult dermatology outpatients, J Coll Physicians Surg Pak, 20, 811
- Choi, 2010, Quality of life and psychological adaptation of Korean adolescents with vitiligo, J Eur Acad Dermatol Venereol, 24, 524, 10.1111/j.1468-3083.2009.03452.x · DOI · Paper page
- Balaban, 2011, Psychiatric morbidity in patients with vitiligo, Dusunen Adam, 24, 306, 10.5350/DAJPN2011240406 · DOI
- Chan, 2011, Investigating factors associated with depression of vitiligo patients in Singapore, J Clin Nurs, 21, 1614, 10.1111/j.1365-2702.2011.03777.x · DOI
- Yamamoto, 2011, Application of a two-question screening instrument to detect depressive symptoms in patients with vitiligo: a pilot study, J Am Acad Dermatol, 64, e69, 10.1016/j.jaad.2010.05.031 · DOI
- Karelson, 2013, Quality of life and emotional state in vitiligo in an Estonian sample: Comparison with psoriasis and healthy controls, Acta Dermato Venereologica., 93, 446, 10.2340/00015555-1520 · DOI · Paper page
- Chan, 2013, Investigating factors associated with quality of life of vitiligo patients in Singapore, Int J Nurs Pract, 19, 3, 10.1111/ijn.12179 · DOI
- Ajose, 2013, Quantification and comparison of psychiatric distress in African patients with albinism and vitiligo: a 5-year prospective study, J Eur Acad Dermatol Venereol, 28, 925, 10.1111/jdv.12216 · DOI
- Ramakrishna, 2014, Psychiatric morbidity and quality of life in vitiligo patients, Indian J Psychol Med, 36, 302, 10.4103/0253-7176.135385 · DOI
- Alshahwan, 2015, The prevalence of anxiety and depression in Arab dermatology patients, J Cutan Med Surg, 19, 297, 10.2310/7750.2014.14110 · DOI
- Saleki, 2015, Prevalence and frequency of depression in patients with vitiligo, Int J Curr Microbiol Appl Sci, 4, 437
- Karia, 2015, Psychiatric morbidity and quality of life in skin diseases: a comparison of alopecia areata and psoriasis, Ind Psychiatry J, 24, 125, 10.4103/0972-6748.181724 · DOI
- Tsintsadze, 2015, Psychosomatic aspects in patients with dermatologic diseases, Georgia Medic News, 243, 70
- Elbuluk, 2017, Quality of life, burden of disease, co-morbidities, and systemic effects in vitiligo patients, Dermatol Clin, 35, 117, 10.1016/j.det.2016.11.002 · DOI
Cited by
Bergqvist, C., & Ezzedine, K. (2020) · Dermatology · doi:10.1159/000506103 · Cited by 799
Vitiligo: A focus on pathogenesis and its therapeutic implications
Bergqvist, C., & Ezzedine, K. (2021) · The Journal of Dermatology · doi:10.1111/1346-8138.15743 · Cited by 277
Psychosocial effects of vitiligo: a systematic literature review
Ezzedine, K., Eleftheriadou, V., Jones, H., Bibeau, K., Kuo, F. I., Sturm, D., & Pandya, A. G. (2021) · American Journal of Clinical Dermatology · doi:10.1007/s40257-021-00631-6 · Cited by 276
Vitiligo prevalence and quality of life among adults in Europe, Japan, and the USA
Bibeau, K., Pandya, A. G., Ezzedine, K., Jones, H., Gao, J., Lindley, A., & Harris, J. E. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18257 · Cited by 137
British Association of Dermatologists guidelines for the management of people with vitiligo 2021
Eleftheriadou, V., Atkar, R., Batchelor, J., McDonald, B., Novakovic, L., Patel, J. V., Ravenscroft, J., Rush, E., Shah, D., Shah, R., et al. (2022) · British Journal of Dermatology · doi:10.1111/bjd.20596 · Cited by 122
Self-citation
Metadata
- Authors
- Osinubi, O., Grainge, M. J., Hong, L., Ahmed, A., Batchelor, J. M., Grindlay, D., Thompson, A. R., & Ratib, S.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-04-01
- Volume
- 178
- Issue
- 4
- Pages
- 863-878
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W2762693917
- Cited by
- 119
- References
- 5
- FWCI
- 0.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.